Menu

More Answers or More Questions?

| Teresa Miceli

As the 57th Annual Meeting and Exposition of the American Society of Hematology (ASH) comes to an end, I come to the overwhelming sense that I may now have more questions than answers. Yes, we have had a “November to Remember” with three new drugs receiving Food and Drug Administration (FDA) approval for treating relapsed […]

Tick-tock, tick-tock…

| Teresa Miceli

The clock is ticking . . . the time nears for the 57th annual American Society of Hematology (ASH) meeting. Again this year, I am privileged to return as part of the International Myeloma Foundation (IMF) Support Group Leaders (SGL) program as an SGL representative and nurse liaison. With this honor comes preparation to make […]